These novel treatments, Retatrutide, represent a groundbreaking advancement in treating obesity and potentially related disorders. They are grouped as GLP-1 pathway stimulators, meaning they function to emulate the natural GLP-1 substance , enhancing insulin production and reducing hunger . Despite Retatrutide each functions relatively similarly, t